| Current Price | $90.94 | Mkt Cap | $36.8B |
|---|---|---|---|
| Open | $93.67 | P/E Ratio | 106.10 |
| Prev. Close | $90.94 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $90.24 - $94.36 | Volume | 3,026,811 |
| 52-Wk Range | $85.31 - $139.55 | Avg. Daily Vol. | 3,868,215 |
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
| Current Price | $90.94 | Mkt Cap | $36.8B |
|---|---|---|---|
| Open | $93.67 | P/E Ratio | 106.10 |
| Prev. Close | $90.94 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $90.24 - $94.36 | Volume | 3,026,811 |
| 52-Wk Range | $85.31 - $139.55 | Avg. Daily Vol. | 3,868,215 |
The best Bull and Bear pitches based on recency and number of recommendations.
Priced right based on DCF analysis, high projected growth rates, growing sales and free cash flow.
The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.
Read the most recent pitches from players about DXCM.
Recs
CMFBLSH
(< 20)
Submitted: 8/10/2023 1:04:28 PM :
Start Price:
$113.84
NASDAQ:DXCM Score:
-14.89
sold off b/c of LLY/NVO news on obesity drug for helping diabetes...
Recs
dreamjob
(76.03)
Submitted: 7/3/2023 4:40:43 PM :
Start Price:
$126.58
NASDAQ:DXCM Score:
-23.56
Priced right based on DCF analysis, high projected growth rates, growing sales and free cash flow.
Recs
lemiwinx
(< 20)
Submitted: 8/2/2022 10:15:52 AM :
Start Price:
$86.82
NASDAQ:DXCM Score:
+2.09
Best diabetes stock. Best in class devices for monitoring diabetes.
Find the members with the highest scoring picks in DXCM.
ardys13 (< 20) Score: +9,339.97
The Score Leader is the player with the highest score across all their picks in DXCM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| ardys13 | < 20 | 2/9/2009 |
|
1Y | $0.93 | +9,731.35% | +391.38% | +9,339.97 | 1 Comment | |
| bigrick22 | < 20 | 3/24/2008 |
|
NS | $1.00 | +8,994.00% | +227.96% | +8,766.04 | 0 Comment | |
| CleverKat | 62.72 | 3/24/2008 |
|
NS | $1.07 | +8,418.97% | +224.38% | +8,194.59 | 0 Comment | |
| cpalerm | 98.61 |
|
|
5Y | $1.08 | +8,320.37% | +441.01% | +7,879.36 | 1 Comment | |
| MEGIN7790 | < 20 | 4/4/2008 |
|
NS | $1.11 | +8,074.38% | +218.15% | +7,856.23 | 0 Comment | |
| LazyTimeMoney | 65.69 | 4/7/2008 |
|
NS | $1.26 | +7,117.46% | +217.62% | +6,899.84 | 0 Comment | |
| jabrink | 74.91 | 4/7/2008 |
|
3W | $1.27 | +7,074.75% | +217.36% | +6,857.39 | 0 Comment | |
| GriffinRex | 89.37 | 4/8/2008 |
|
3M | $1.29 | +6,935.98% | +220.92% | +6,715.06 | 0 Comment | |
| cash4metoo | 56.90 | 5/28/2009 |
|
1Y | $1.34 | +6,711.99% | +370.92% | +6,341.07 | 0 Comment | |
| YahooSIRIous | 93.01 | 7/13/2009 |
|
5Y | $1.34 | +6,699.25% | +379.69% | +6,319.57 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
